- IN₹130.27bn
- IN₹114.52bn
- IN₹28.39bn
- 91
- 17
- 55
- 57
Annual balance sheet for Indegene, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,399 | 6,372 | 6,999 | 9,875 | 16,643 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2,861 | 4,467 | 6,755 | 6,800 | 8,052 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 4,593 | 11,300 | 14,487 | 17,908 | 25,300 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 464 | 799 | 1,456 | 1,144 | 1,385 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 5,960 | 13,535 | 22,039 | 25,456 | 33,259 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,994 | 4,404 | 4,891 | 6,109 | 5,645 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 2,715 | 5,896 | 11,401 | 11,165 | 7,103 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 3,245 | 7,639 | 10,637 | 14,291 | 26,156 |
| Total Liabilities & Shareholders' Equity | 5,960 | 13,535 | 22,039 | 25,456 | 33,259 |
| Total Common Shares Outstanding |